# PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)

> **NCT00839566** · PHASE4 · TERMINATED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 12 (actual)

## Conditions studied

- Atrial Fibrillation
- Heart Failure

## Interventions

- **PROCEDURE:** Ablation
- **OTHER:** Rate Control

## Key facts

- **NCT ID:** NCT00839566
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2012-03
- **Final completion:** 2012-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Number of eligible patients too small.
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00839566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00839566, "PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00839566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*